Cardio Diagnostics (NASDAQ:CDIO) Releases Quarterly Earnings Results

Cardio Diagnostics (NASDAQ:CDIO) posted its quarterly earnings results on Friday. The company reported ($0.80) EPS for the quarter, Zacks reports. Cardio Diagnostics had a negative net margin of 39,674.18% and a negative return on equity of 67.51%.

Cardio Diagnostics Price Performance

Shares of CDIO stock opened at $2.80 on Friday. Cardio Diagnostics has a 1-year low of $0.97 and a 1-year high of $17.39. The stock’s 50-day moving average is $2.68 and its 200 day moving average is $3.33. The company has a market cap of $5.12 million, a P/E ratio of -0.75 and a beta of 2.28.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Cardio Diagnostics in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Institutional Trading of Cardio Diagnostics

A hedge fund recently raised its stake in Cardio Diagnostics stock. DRW Securities LLC raised its position in shares of Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) by 122.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 40,463 shares of the company’s stock after buying an additional 22,298 shares during the quarter. DRW Securities LLC owned about 2.21% of Cardio Diagnostics worth $110,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 8.06% of the company’s stock.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.